Patients and methods
From March 1983 to September 1986, 348 consecutive patients were admitted to this unit with acute viral hepatitis. The diagnosis was made if the patients gave histories of characteristic symptoms, and if there were signs of acute viral hepatitis with abnormal liver function tests. Only patients with viral hepatitis were included in the study.
The following information was recorded for each patient: sex, age, any recent injections, any recent transfusion of blood products, family history of hepatitis, recent contact with someone with hepatitis, recent journeys abroad, consumption of shellfish, any drugs taken, and the state of hygiene in the home. Samples of blood were taken on admission and during the second week in hospital for estimations of months. Patients with hepatitis B seemed to recover more slowly, and one patient with non-A, non-B hepatitis developed chronic persistent hepatitis. Table 4 shows the hepatitis B surface antigen clearance rate, and the seroconversion rate. Only one patient became a chronic carrier of hepatitis B surface antigen, and his liver function was normal. Of the 34 patients with hepatitis A and the nine with non-A, non-B hepatitis who were positive for hepatitis B surface antigen on admission, 27 and eight, respectively, became chronic carriers.
Discussion
There are few reports of studies of the aetiology and clinical course of hepatitis in children.1 2 Our study was carried out in an area where there is not only a high incidence of hepatitis but also a hih incidence of hepatitis B in the general population. As in other countries, however, hepatitis A is the most common form in children.2 4 This suggests that children have contact with the hepatitis A virus early in childhood, which confirms the findings of a previous study that Acute viral hepatitis: aetiology and evolution 213 by the ages of 5, 10, and 15 years, 10%, 15%, and 44%, respectively already have antibodies to hepatitis A virus.5 Our finding that hepatitis B and non-A, non-B hepatitis were found only in 8% and 10% of our group of children with acute hepatitis is in contrast with the findings of others in adults. 6 There are three principal modes of transmission of hepatitis B infection in Hong Kong: infection of newborn infants by mothers who are carriers, which accounts for the comparatively high incidence in infancy; transmission from friends and family members, which accounts for the second peak at about 11 to 15 years of age; and sexual transmission, which accounts for the pronounced increase in young adults. 3 Non-A, non-B hepatitis, which is rare in Italy, was comparatively common in our series accounting for 10% of the cases. 1 As with hepatitis B it was more common in infants, then the incidence dropped before rising again after the age of about 10 years; in adults in Hong Kong it accounts for about 35% of cases.5 In the seven cases in our series who were also hepatitis B surface antigen positive, none had antidelta antibodies.
We confirm the findings of most reports that systemic symptoms were more common in patients with hepatitis A. It was noteworthy that jaundice was not a presenting feature in about half the cases of non-A, non-B hepatitis, and rashes and arthritis were more common in patients with hepatitis B.
We are also able to confirm from these data that patients with hepatitis A always recover, and do so more quickly than patients with hepatitis B. There are few data about the progression of acute hepatitis B to chronic liver disease in children,'1 7 but Caporaso et al in Naples reported that two years after the acute attack there was histological evidence of chronic disease in 10 of 42 cases (24%); they found chronic active hepatitis in four, chronic persistent hepatitis in one, and chronic lobular hepatitis in another.1 They did not study delta infection, which is common in Italy and rare in Hong Kong, and this may explain why none of our patients with hepatitis B went on to develop chronic liver disease and only one became a carrier of hepatitis B surface antigen.
The only case that progressed to chronic liver disease was of non-A, non-B hepatitis. The incidence varies from series to series, probably because there are at least three types of non-A, non-B hepatitis; there is the type that is transmitted by blood (B type), the type that is transmitted by the coagulation factor, and the epidemic water borne type (A type).9 Chronic liver disease often follows the B type, but rarely the A type. It is likely that our non-A, non-B cases were of the B type. None of our patients had previously had a blood transfusion; the possible methods of transmission are from close members of the family, through intimate contact and sharing of household utensils and toothbrushes. Clusters of cases in households have been reported. 
